K006384PAnti-CPEB4 (N-term) Polyclonal Antibody
- 发布日期: 2020-03-04
- 更新日期: 2026-01-16
产品详请
| 产地 |
北京
|
| 品牌 |
solarbio
|
| 货号 |
K006384P
|
| 保存条件 |
Store at -20°C. Avoid freeze / thaw cycles.
|
| 用途 |
蛋白研究,分析,检测
|
| 应用范围 |
WB IHC-P
|
| 抗原来源 |
|
| CAS编号 |
|
| 保质期 |
|
| 抗体名 |
Anti-CPEB4 (N-term) Polyclonal Antibody
|
| 是否单克隆 |
否
|
| 克隆性 |
|
| 靶点 |
CPEB4 (N-term)
|
| 适应物种 |
Human Mouse
|
| 形态 |
液体
|
| 宿主 |
Rabbit
|
| 标记物 |
|
| 包装规格 |
50ul
|
| 纯度 |
%
|
| 亚型 |
Ig
|
| 标识物 |
|
| 浓度 |
%
|
| 免疫原 |
synthetic peptide between 109-137 amino acids
|
| 是否进口 |
否
|
背景资料:Sequence-specific RNA-binding protein that binds to the cytoplasmic polyadenylation element (CPE), an uridine-rich sequence element (consensus sequence 5'-UUUUUAU-3') within the mRNA 3'-UTR (PubMed:24990967). RNA binding results in a clear conformational change analogous to the Venus fly trap mechanism (PubMed:24990967). Regulates activation of unfolded protein response (UPR) in the process of adaptation to ER stress in liver, by maintaining translation of CPE-regulated mRNAs in conditions in which global protein synthesis is inhibited (By similarity). Required for cell cycle progression, specifically for cytokinesis and chromosomal segregation (PubMed:26398195). Plays a role as an oncogene promoting tumor growth and progression by positively regulating translation of t-plasminogen activator/PLAT (PubMed:22138752). Stimulates proliferation of melanocytes (PubMed:27857118). In contrast to CPEB1 and CPEB3, does not play role in synaptic plasticity, learning and memory (By similarity).